Press Releases

Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director of Roswell Park Comprehensive Cancer Center, will give an update about an ongoing clinical trial at the American Society of Clinical Oncology (ASCO) 53rd Annual Meeting in Chicago. Dr. Odunsi, who is also Chair of Gynecologic Oncology and Executive Director of the Center for Immunotherapy at Roswell Park, will report on the status and methods of the clinical study, which is assessing the safety and antitumor activity of an approach that employs T-cell engineering to stimulate the immune system against ovarian cancer.

More than 10 teams from Roswell Park Comprehensive Cancer Center have been invited to present research at the American Society of Clinical Oncology (ASCO) 53rd Annual Meeting in Chicago. The research presentations cover a wide range of disciplines, treatment approaches and cancer types, including a unique form of immunotherapy for ovarian cancer, promising results on a new treatment approach for Hodgkin lymphoma in children and young adults and an effort to build a predictive tool to determine which patients are most likely to respond well to checkpoint inhibitors.

Researchers at Roswell Park Comprehensive Cancer Center have garnered $6.4 million in new grant funding to support important investigations, including an award of more than $2 million from the National Cancer Institute to Yuesheng Zhang, MD, PhD, Professor of Oncology in the Department of Pharmacology & Therapeutics, for his research to improve colorectal cancer treatment.

BUFFALO, N.Y. — It’s estimated that there are more than 15.5 million cancer survivors living in the United States, with that number expected to rise dramatically over the next two decades.

A new study led by researchers at Roswell Park Comprehensive Cancer Center establishes a connection between a sedentary lifestyle and risk of developing kidney or bladder cancer. The findings extend a line of inquiry that has already revealed a connection between chronic inactivity and heightened risk for both ovarian and cervical cancer, and also highlight the possibility of reducing risk for some cancers by increasing physical activity.

Roswell Park Comprehensive Cancer Center has been named to Forbes’ 2017 list of America’s Best Employers. The Buffalo, N.Y., comprehensive cancer center was ranked 169th on the media organization’s list of 300 Best Midsize Employers across 25 industries.

More than 10 nursing teams from Roswell Park Comprehensive Cancer Center were invited to present their research at the 42nd Annual Congress of the Oncology Nursing Society (ONS) May 4–7, 2017, in Denver, Colorado.

In a new study, Roswell Park Comprehensive Cancer Center researchers have demonstrated that an approach shown to improve outcomes for patients receiving colorectal surgery is just as effective in patients requiring many other abdominal and pelvic operations.

Pawel Kalinski, MD, PhD, has joined Roswell Park Comprehensive Cancer Center as Vice Chair for Translational Research within the Department of Medicine and Director of Cancer Vaccine and Dendritic Cell Therapies within the Center for Immunotherapy.